Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beleave Inc BLEVF

Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.


GREY:BLEVF - Post by User

Bullboard Posts
Comment by JustinLawon Feb 21, 2017 8:51am
134 Views
Post# 25871377

RE:Big things happening

RE:Big things happeningI have a few "friends" at ryerson who said there's lots of talk that beleave will be the darling of the industry in terms of grants and further partnerships. Lots of visitors from abroad looking at the research. Beleave's focus is not just on getting high and cashing in but rather the world wide appetite and demand for mj derived drugs with no illicit effects on the human condition. This is where big pharma wants in. Ryerson's partnership isn't just a quick money grab it's an opening into a much larger picture where it becomes legitimized with the backdrop of support from government programs and schools. Thanks
Bullboard Posts